Stem Cell‐Derived Exosomes as Nanotherapeutics for Inflammatory Diseases
Authors:
Open Access
- 23 March 2025
- journal article
- Published by Wiley in MedComm – Future Medicine
- Vol. 4 (1)
Abstract
Inflammation, as a complex biological response, can lead to tissue damage and pathological physiological changes, forming the basis for many chronic diseases. Stem cell‐derived exosomes (SC‐Exos), a type of nanoscale extracellular vesicle, possess advantages such as small volume, low immunogenicity, and drug‐carrying capacity, demonstrating immense potential in the field of disease diagnostics and therapeutics. Current studies indicate that SC‐Exos can not only alleviate inflammatory diseases by suppressing inflammatory cytokines and modulating the activation of macrophages through their immunomodulatory and regenerative properties but also show significant potential as carriers for anti‐inflammatory drugs, presenting a promising therapeutic approach for inflammatory conditions. However, the current lack of systematic summaries of SC‐Exos in the treatment of inflammatory diseases has impeded the development of standardized therapies and clinical applications. This review elucidates the methods of SC‐Exo sourcing, isolation, characterization, and engineering, as well as their application, mechanisms of action, and efficacy in the treatment of inflammatory diseases such as periodontitis, osteoarthritis (OA), and inflammatory bowel disease. Integrating these findings, this review highlights that SC‐Exos can attenuate a variety of inflammatory diseases by transporting a diverse range of molecules to modulate immune responses, thereby providing foundations for subsequent standardization of production and clinical trials.Keywords
This publication has 167 references indexed in Scilit:
- Human Amniotic Epithelial Stem Cells Promote Colonic Recovery in Experimental Colitis via Exosomal MiR‐23a–TNFR1–NF‐κB SignalingAdvanced Science, 2024
- Engineered brain‐targeting exosome for reprogramming immunosuppressive microenvironment of glioblastomaExploration, 2024
- Treatment with Mesenchymal Stem Cell‐Derived Nanovesicle‐Containing Gelatin Methacryloyl Hydrogels Alleviates Osteoarthritis by Modulating Chondrogenesis and Macrophage PolarizationAdvanced Healthcare Materials, 2023
- ADSCs‐exo attenuates hepatic ischemia–reperfusion injury after hepatectomy by inhibiting endoplasmic reticulum stress and inflammationJournal of Cellular Physiology, 2023
- Synergistic Therapy of a Naturally Inspired Glycopolymer‐Based Biomimetic Nanomedicine Harnessing Tumor Genomic InstabilityAdvanced Materials, 2021
- Adipose‐derived mesenchymal stem cell‐secreted exosome alleviates dextran sulfate sodium‐induced acute colitis by Treg cell induction and inflammatory cytokine reductionJournal of Cellular Physiology, 2021
- Exosomes from mesenchymal stem cells overexpressing MIF enhance myocardial repairJournal of Cellular Physiology, 2020
- Exosomal microRNA‐155‐5p from PDLSCs regulated Th17/Treg balance by targeting sirtuin‐1 in chronic periodontitisJournal of Cellular Physiology, 2019
- A Cytoprotective and Degradable Metal–Polyphenol Nanoshell for Single‐Cell EncapsulationAngewandte Chemie International Edition, 2014
- Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti‐inflammatory actionGlia, 2008